KRYSTAL BIOTECH INC. - COMMON STOCK

Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

06 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer

14 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer

18 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels

12 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa

09 Dec 2024 16:15:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at Upcoming Investor Conferences

27 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at Stifel 2024 Healthcare Conference

12 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

06 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

04 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024

28 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference

13 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

06 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté

28 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates

05 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024

26 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference

05 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at the American Thoracic Society 2024 International Conference

15 May 2024 07:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

08 May 2024 07:00:01 By Nasdaq GlobeNewswire

Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates

06 May 2024 08:00:00 By Nasdaq GlobeNewswire

Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting

02 May 2024 07:00:00 By Nasdaq GlobeNewswire